Envoy Medical, Inc. (NASDAQ:COCH) Director Mona Chetan Patel Purchases 4,000 Shares

Envoy Medical, Inc. (NASDAQ:COCH) Director Mona Chetan Patel acquired 4,000 shares of Envoy Medical stock in a transaction that occurred on Wednesday, September 11th. The stock was purchased at an average price of $3.33 per share, with a total value of $13,320.00. Following the transaction, the director now owns 5,000 shares of the company’s stock, valued at $16,650. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Mona Chetan Patel also recently made the following trade(s):

• On Monday, September 9th, Mona Chetan Patel acquired 1,000 shares of Envoy Medical stock. The stock was purchased at an average price of $3.20 per share, with a total value of $3,200.00.

Envoy Medical Price Performance

Shares of COCH opened at $3.25 on Thursday. The firm has a 50 day simple moving average of $2.58 and a 200-day simple moving average of $3.54. Envoy Medical, Inc. has a 1-year low of $0.75 and a 1-year high of $11.72.

Envoy Medical (NASDAQ:COCH) last issued its quarterly earnings data on Monday, August 12th. The company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.03). The firm had revenue of $0.07 million for the quarter, compared to analyst estimates of $0.08 million. Equities analysts forecast that Envoy Medical, Inc. will post -1.36 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets increased their target price on shares of Envoy Medical from $8.50 to $8.75 and gave the company a “buy” rating in a report on Tuesday, September 3rd.

Institutional Trading of Envoy Medical

Hedge funds have recently bought and sold shares of the company. Weiss Asset Management LP acquired a new stake in Envoy Medical during the fourth quarter worth approximately $37,000. WealthTrust Asset Management LLC acquired a new position in shares of Envoy Medical in the 1st quarter valued at $44,000. Finally, Virtu Financial LLC acquired a new position in shares of Envoy Medical in the 1st quarter valued at $55,000. Institutional investors and hedge funds own 8.59% of the company’s stock.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.